Characteristics of Autism Spectrum Disorder in Minors With Anorexia Nervosa in Remission

September 17, 2019 updated by: Universitair Ziekenhuis Brussel
With this investigation, researchers wil look for a link between the appearance of anorexia nervosa and autism spectrum disorders in minors. Previous studies made clear already that patients with anorexia nervosa show elevated characteristics of autism spectrum disorder, when being meassured in adults and in patients in the acute fase of their anorexia nervosa. The purpose of this invenstigation is to see if their is also an elevated incidence of characteristics of autism spectrum disorder in minors with anorexia nervosa in remission.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

34 patients who are still minors and were previously treated in the Child and Adolescent Psychiatry Department (PAika) of the University Hospital in Brussels, will be contacted to ask if they would volunteer in this investigation. If the minors and their parents give their permission, they will be asked to fill in multiple questionnaires, measuring the current symptoms of anorexia nervosa, characteristics of autism spectrum disorder and global functioning of the minors. The questionnaires will be send and returned by post.

Study Type

Observational

Enrollment (Anticipated)

34

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Belgium
      • Brussel, Belgium
        • UZ Brussel
        • Contact:
          • Sara Wouters, Dr.
        • Sub-Investigator:
          • Joni Roelandt, Dr.
        • Sub-Investigator:
          • Herbert Roeyers, Prof. dr.
        • Principal Investigator:
          • Sara Wouters, Dr.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 18 years (ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients were previously treated in UZ Brussel for anorexia nervosa. Intake happened at least one year ago.

Description

Inclusion Criteria:

  • Patients speaking Dutch
  • Previously treated in UZ Brussel for anorexia nervosa
  • Informed consent signed by children and parent(s)

Exclusion Criteria:

  • Patients and/or parents don't speak Dutch
  • Adults
  • No informed consent obtained

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Symptoms of autism spectrum disorder
Time Frame: The measurment will be done once during the period of October 2019 to March 2020.
Symptoms of autism spectrum disorder will be measured by questionnaires, filled in by the minors (by the Autism-spectrum Quotient) and their parents (by the Social Responsiveness Scale-2 and the Social Communication Questionnaire).
The measurment will be done once during the period of October 2019 to March 2020.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Global functioning
Time Frame: The measurment will be done once during the period of October 2019 to March 2020
Global functioning will be measured by questionnaires, filled in by the minors (by the Youth Self Report) and their parents (by the Child Behavior Checklist).
The measurment will be done once during the period of October 2019 to March 2020
Symptoms of anorexia nervosa
Time Frame: The measurment will be done once during the period of October 2019 to March 2020
Symptoms of anorexia nervosa will be measured by questionnaires, filled in by the minors (by the Eating Disorder Examination Questionnaire and the Child Eating Disorder Examination Questionnaire) and their parents (by the Anorectic Behavior Observation Scale).
The measurment will be done once during the period of October 2019 to March 2020

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universitair Ziekenhuis Brussel

Collaborators

University Ghent

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

October 1, 2019

Primary Completion (ANTICIPATED)

March 31, 2020

Study Completion (ANTICIPATED)

March 31, 2020

Study Registration Dates

First Submitted

April 17, 2019

First Submitted That Met QC Criteria

September 17, 2019

First Posted (ACTUAL)

September 19, 2019

Study Record Updates

Last Update Posted (ACTUAL)

September 19, 2019

Last Update Submitted That Met QC Criteria

September 17, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PAIKA2019STUDIE01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anorexia Nervosa

Clinical Trials on Questionnaires

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe